These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 21195182)

  • 1. Analyzing the aggregation of polyglutamine-expansion proteins and its modulation by molecular chaperones.
    Kubota H; Kitamura A; Nagata K
    Methods; 2011 Mar; 53(3):267-74. PubMed ID: 21195182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular chaperones as modulators of polyglutamine protein aggregation and toxicity.
    Sakahira H; Breuer P; Hayer-Hartl MK; Hartl FU
    Proc Natl Acad Sci U S A; 2002 Dec; 99 Suppl 4(Suppl 4):16412-8. PubMed ID: 12189209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monitoring polyglutamine toxicity in yeast.
    Duennwald ML
    Methods; 2011 Mar; 53(3):232-7. PubMed ID: 21144902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multi-domain misfolding: understanding the aggregation pathway of polyglutamine proteins.
    Saunders HM; Bottomley SP
    Protein Eng Des Sel; 2009 Aug; 22(8):447-51. PubMed ID: 19589877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mimicking proteasomal release of polyglutamine peptides initiates aggregation and toxicity.
    Raspe M; Gillis J; Krol H; Krom S; Bosch K; van Veen H; Reits E
    J Cell Sci; 2009 Sep; 122(Pt 18):3262-71. PubMed ID: 19690053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polyglutamine expansion mutation yields a pathological epitope linked to nucleation of protein aggregate: determinant of Huntington's disease onset.
    Sugaya K; Matsubara S; Kagamihara Y; Kawata A; Hayashi H
    PLoS One; 2007 Jul; 2(7):e635. PubMed ID: 17653262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chaperonin TRiC promotes the assembly of polyQ expansion proteins into nontoxic oligomers.
    Behrends C; Langer CA; Boteva R; Böttcher UM; Stemp MJ; Schaffar G; Rao BV; Giese A; Kretzschmar H; Siegers K; Hartl FU
    Mol Cell; 2006 Sep; 23(6):887-97. PubMed ID: 16973440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Aggregation and toxicity of the proteins with polyQ repeats].
    Leźnicki P
    Postepy Biochem; 2005; 51(2):215-22. PubMed ID: 16209359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polyglutamine and polyalanine expansions in ataxin7 result in different types of aggregation and levels of toxicity.
    Latouche M; Fragner P; Martin E; El Hachimi KH; Zander C; Sittler A; Ruberg M; Brice A; Stevanin G
    Mol Cell Neurosci; 2006 Mar; 31(3):438-45. PubMed ID: 16325416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surface plasmon resonance characterization of specific binding of polyglutamine aggregation inhibitors to the expanded polyglutamine stretch.
    Okamoto Y; Nagai Y; Fujikake N; Akiko Popiel H; Yoshioka T; Toda T; Inui T
    Biochem Biophys Res Commun; 2009 Jan; 378(3):634-9. PubMed ID: 19061859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The rate of polyQ-mediated aggregation is dramatically affected by the number and location of surrounding domains.
    Robertson AL; Bate MA; Buckle AM; Bottomley SP
    J Mol Biol; 2011 Nov; 413(4):879-87. PubMed ID: 21945530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel mechanism of Hsp70 chaperone-mediated prevention of polyglutamine aggregates in a cellular model of huntington disease.
    Guzhova IV; Lazarev VF; Kaznacheeva AV; Ippolitova MV; Muronetz VI; Kinev AV; Margulis BA
    Hum Mol Genet; 2011 Oct; 20(20):3953-63. PubMed ID: 21775503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sir2 is induced by oxidative stress in a yeast model of Huntington disease and its activation reduces protein aggregation.
    Sorolla MA; Nierga C; Rodríguez-Colman MJ; Reverter-Branchat G; Arenas A; Tamarit J; Ros J; Cabiscol E
    Arch Biochem Biophys; 2011 Jun; 510(1):27-34. PubMed ID: 21513696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conformational changes and aggregation of expanded polyglutamine proteins as therapeutic targets of the polyglutamine diseases: exposed beta-sheet hypothesis.
    Nagai Y; Popiel HA
    Curr Pharm Des; 2008; 14(30):3267-79. PubMed ID: 19075705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The structural impact of a polyglutamine tract is location-dependent.
    Robertson AL; Horne J; Ellisdon AM; Thomas B; Scanlon MJ; Bottomley SP
    Biophys J; 2008 Dec; 95(12):5922-30. PubMed ID: 18849414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Huntington toxicity in yeast model depends on polyglutamine aggregation mediated by a prion-like protein Rnq1.
    Meriin AB; Zhang X; He X; Newnam GP; Chernoff YO; Sherman MY
    J Cell Biol; 2002 Jun; 157(6):997-1004. PubMed ID: 12058016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disruption of the toxic conformation of the expanded polyglutamine stretch leads to suppression of aggregate formation and cytotoxicity.
    Popiel HA; Nagai Y; Onodera O; Inui T; Fujikake N; Urade Y; Strittmatter WJ; Burke JR; Ichikawa A; Toda T
    Biochem Biophys Res Commun; 2004 May; 317(4):1200-6. PubMed ID: 15094397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PolyQ fibrillation in the cell nucleus: who's bad?
    von Mikecz A
    Trends Cell Biol; 2009 Dec; 19(12):685-91. PubMed ID: 19796946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polyglutamine expansion of huntingtin impairs its nuclear export.
    Cornett J; Cao F; Wang CE; Ross CA; Bates GP; Li SH; Li XJ
    Nat Genet; 2005 Feb; 37(2):198-204. PubMed ID: 15654337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The potential of indole and a synthetic derivative for polyQ aggregation reduction by enhancement of the chaperone and autophagy systems.
    Lin CH; Wu YR; Kung PJ; Chen WL; Lee LC; Lin TH; Chao CY; Chen CM; Chang KH; Janreddy D; Lee-Chen GJ; Yao CF
    ACS Chem Neurosci; 2014 Oct; 5(10):1063-74. PubMed ID: 25197952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.